TYE-1317

N/A

Report date: 2024/01/16 17:48:03

Base Information

Drug NameTYE-1317
Drug Alias NameTYE-1317Tye1317
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Tyercan Bio-pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Tyercan Bio-pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A